573 Results (Page 21 of 23)
France Markets Research Reports
France Diabetes Devices Market Analysis
The France Diabetes Devices Market is expected to witness growth from $625 Mn in 2022 to $1011 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In France, insulin pumps have become increasingly popular due to their ability to improve glycemic control and enhance the quality of life for diabetes patients in France. Manufacturers that offer insulin pumps with advanced features and better usability are likely to see growth in the market. The market is segmented by type and by the end user. Some key players in this market include Nanosonics France, SAMMEX Medical, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
France Cardiac Surgery Instruments Market Analysis
The France Cardiac Surgery Instruments Market is expected to witness growth from $57 Mn in 2022 to $88 Mn in 2030 with a CAGR of 5.60% for the forecasted year 2022-2030. The market for heart surgical devices in France is expanding as less invasive techniques become more popular. Because they are less intrusive, these procedures have quicker recovery periods and fewer complications, which is encouraging both patients and healthcare professionals to use them more frequently. The market is segmented by type, application and by end user. Some key players in this market include Delacroix-Chevalier, Marquat, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
France Cardiovascular Diseases Therapeutics Market Analysis
France's cardiovascular disease therapeutics market is projected to grow from $4.47 Bn in 2022 to $7.24 Bn in 2030 with a CAGR of 6.22% for the year 2022-2030. The rising prevalence of cardiovascular diseases in France and consequently increased healthcare spending in France are the major market drivers for the growth of the market. The France cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Medac, Laboratoires Boiron, and AstraZeneca are the major players in the France cardiovascular disease therapeutics market.
France Anti Aging Therapeutics Market Analysis
France anti-aging therapeutics market is expected to witness growth from $17 Mn in 2022 to $53 Mn in 2030 with a CAGR of 15.53% for the year 2022-2030. The presence of robust research and development industry in France makes it a popular destination for the testing of anti-aging therapeutics thereby resulting in the growth of the market. The France anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Cottos, DBV Technologies, and Allergan.
France Healthcare Claims Management Market Analysis
The France healthcare claims management market is projected to grow from $734.25 Mn in 2022 to $3699.09 Mn by 2030, registering a CAGR of 22.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, government initiatives, the ageing population and increasing privatization. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Almerys, Cegedim, Prima Solutions, Accenture, Cognizant and Genpact.
France Artificial Intelligence (AI) in Healthcare Market Analysis
France's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.19 Bn in 2022 to $3.55 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-30. The market will be driven by the increasing healthcare demands and the strong healthcare system of France. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Therapixel & Moon Surgical.
France Healthcare Insurance Market Analysis
The France healthcare insurance market is projected to grow from $55.72 Bn in 2022 to $92.91 Bn by 2030, registering a CAGR of 6.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, the ageing population, technological innovation, increased awareness and demand for healthcare insurance. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Credit Agricole, Groupama, Harmonie Mutuelle, CNP and MGEN.
France ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
France's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $813 Mn in 2022 to $1,345 Mn in 2030 with a CAGR of 6.5% for the year 2022-30. The increased prevalence of ADHD in France and rising investments in mental health services are the major market drivers for the growth of the market. The France ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Novasep, Poxel, and Adlon Therapeutics are the key players in the market.
France Oncology Clinical Trials Market Analysis
The France oncology clinical trials market is projected to grow from $347.9 Mn in 2022 to $494.7 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022-30. The market will be driven by the rising prevalence of cancer cases, the modern healthcare system in the nation, and a supportive regulatory framework. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Transgene & Ipsen.
France Diabetes Drugs Market Analysis
The France diabetes drugs market size was valued at $1.69 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030 and will reach $2.52 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The France diabetes drug market will grow because there is a growing focus on preventive measures to reduce the risk of developing diabetes, including lifestyle changes, which is also driving the demand for diabetes management products and services. The key market players are Adocia (FRA), Voluntis (FRA), Biocorp (FRA), CERBA HealthCare (FRA), Boehringer Ingelheim, Sanofi, and others.
France Robotic Surgery Services Market Analysis
France's robotic surgery service market size was valued at $118 Mn in 2022 and is estimated to expand at a CAGR of 18.3% from 2022-30 and will reach $453 Mn in 2030. The robotic surgery service market will grow due to the development of new and improved robotic surgical systems is making these procedures more accessible and affordable, and helping to increase awareness about their benefits among healthcare providers and patients. The market is segmented by product and service type, application type, and end user. Some of the major players are Medtronic, Johnson & Johnson, Stryker, Intuitive Surgical, Smith & Nephewand others
France Artificial Intelligence (AI) in Medical Imaging Market Analysis
France artificial intelligence (AI) in medical Imaging market size was valued at $41 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.4% from 2022 to 2030 and will reach $439 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the France Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market are KineQuantum, Quantificare, Median Technologies, Mirada Medical, CureMetrix, Olea Medical, Aidence, Smart Reporting, CorTechs Labs, and others, and others.
France Neurology Clinical Trials Market Analysis
The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The market will be driven by the growing frequency of neurological diseases and the robust research infrastructure of France. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Sanofi SA & Neuraxpharm France SAS.
France Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the France infectious disease therapeutics market will reach a value of $4.29 Bn from $3.3 Bn in 2022, growing at a CAGR of 3.4% during 2022-2030. The Infectious Disease Therapeutics in France is dominated by a few domestic pharmaceutical companies such as BioMérieux, Sanofi and Institut Mérieux. The Infectious Disease Therapeutics market in France is segmented into different therapeutic areas and different diseases type. The major factors affecting the France infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious diseases treatment in various areas of France.
France Neurology Devices Market Analysis
France's neurology device market size is at around $347.05 Mn in 2022 and is projected to reach $587.44 Mn in 2030, exhibiting a CAGR of 6.8% during the forecast period. France has a high burden of neurology illnesses, and businesses such as Cerveau Technologies, In Vivo Neurotech, and NeuroMed Technologie dominate the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
France Patient Engagement Solutions Market Analysis
The France patient engagement solutions market is projected to grow from $467.78 Mn in 2022 to $1093.64 Mn by 2030, registering a CAGR of 11.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, rising demand for patient-centred care, technological advancements and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Doctolib, Keldoc, Medaviz, Mckesson and Lincor.
France Palliative Care Market Analysis
The France Palliative care market is projected to grow from $359.7 Mn in 2022 to $618.03 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The main factors driving the growth would rise in the aging population, the increase in the prevalence of chronic diseases, and government support. The market is segmented by service type and by the end user. Some of the major players include La Maison, Hospices Civils de Lyon, Jeanne Garnier Medical Center, and Home Instead.
France Cancer Pain Management Market Analysis
France's Cancer Pain Management market is projected to grow from $179.3 Mn in 2022 to $251.1 Mn by 2030, registering a CAGR of 4.3% during the forecast period of 2022-2030. The main factors driving the growth would be government support and initiatives, the aging population, and increasing cancer incidence. The market is segmented by drug type and by disease. Some of the major players include Sanofi (FRA), Ethypharm (FRA), Grunenthal Pharma, Pfizer, Teva Pharmaceuticals, and Abbott.
France Orphan Diseases Drugs Market Analysis
The France Orphan Diseases Drugs Market is projected to grow from $4.257 Bn in 2022 to $8.671 Bn by 2030, registering a CAGR of 9.30% during the forecast period of 2022 - 2030. Some of the most common orphan diseases in France include cystic fibrosis, hereditary angioedema, Huntington's disease, and Gaucher disease. Orphan Europe is a French-based pharmaceutical company specializing in the development and commercialization of drugs for the treatment of rare diseases.
France HIV Therapeutics Market Analysis
By 2030, it is anticipated that the France HIV therapeutics market will reach a value of $433.03 Mn from $378.40 Mn in 2022, growing at a CAGR of 1.7% during 2022-2030. The market is primarily dominated by local players such as Sanofi, Gilead Sciences France, and ViiV Healthcare France. The market is driven by various financial initiatives, increasing awareness campaigns, and the prevalence of the generic drug market. The HIV therapeutics market in France is segmented by type, product, geography, end user, and distribution channel.
France Lung Cancer Drugs Market Analysis
The France Lung Cancer Drug Market is projected to grow from $263 Mn in 2022 to $462 Mn by 2030, registering a CAGR of 7.3% during the forecast period of 2022 - 2030. The key drivers of the France lung cancer drug market include an aging population, increasing incidence of lung cancer, and the availability of new and innovative treatments. The key players in the France lung cancer drug market include pharmaceutical companies such as AstraZeneca, Bristol-Myers Squibb, Pfizer, Roche, and Merck, among others.
France Electronic Health Records Market Analysis
The France Electronic Health Record (EHR) market size was valued at $778 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3% from 2022 to 2030 and will reach $986 Mn in 2030. The market is segmented by product, application, and end user. The France EHR market will grow due to government initiatives to promote the adoption of EHRs. The key market players are Medasys, Infor, GCS, Cerner, Siemens Healthineers, and others.
France Digital Health Market Analysis
The France Digital Health market is projected to grow from $ 5.8Bn in 2022 to $ 21.23Bn by 2030, registering a CAGR of 17.6% during the forecast period of 2022 - 2030. The market seems to be driven by supportive government policies, private digital health investments, and growing demands of the same. The market is segmented by solution, by deployment & by end-use. Some of the major players include Doctolib, Owkin & Meditech.
France Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the France Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the France Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
France Clinical Trials Support Service Market Analysis
This report presents a strategic analysis of the France Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the France Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.
